share_log

美股异动丨礼来盘前涨1% 非洲制药商Aspen助力其减肥药生产

Changes in US stocks 丨 Eli Lilly rose 1% before the market, African pharmaceutical company Aspen helps produce diet pills

Gelonghui Finance ·  Apr 22 16:49
On April 22 | LLY.US (LLY.US) rose 1.06% to $734 in the premarket. According to the news, most doses of Eli Lilly's diabetes drug Mounjaro and weight loss drug Zepbound will be available in limited quantities in the second quarter of this year due to increased demand. Aspen CEO Stephen Saad said Eli Lilly's best-selling diabetes drug Mounjaro will be distributed and promoted throughout southern Africa; the company has the ability to increase the supply of the world's most popular medicines. Saad said that over time, Aspen has also seen opportunities to produce glucagon-like peptide-1 diabetes drugs and high-dose obesity drugs at major factories in South Africa.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment